Americas vs United Republic of Tanzania: Proportion of the target population who received the final dose of
Americas
64.0%
in 2024
United Republic of Tanzania
94.0%
in 2024
Americas rank
6th
United Republic of Tanzania rank
5th
Proportion of the target population who received the final dose of over time
- Americas
- United Republic of Tanzania
How they compare
United Republic of Tanzania currently reports 94.0% against 64.0% in Americas, a difference of 30.0%.
That makes United Republic of Tanzania's figure about 1.5 times Americas's.
The two have swapped places 1 time across 7 shared years of data; in 2018 it was Americas ahead.
Americas ranks 6th and United Republic of Tanzania ranks 5th of 35 groups.
Across the 2 decades both report, Americas averaged higher in 1 and United Republic of Tanzania in 1.
Head to head by decade
| Decade | Americas | United Republic of Tanzania | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 53.5% | 33.0% | 20.5% | Americas |
| 2020s | 50.8% | 71.8% | 21.0% | United Republic of Tanzania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Americas or United Republic of Tanzania?
- United Republic of Tanzania, at 94.0% against 64.0% in Americas as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Americas and United Republic of Tanzania?
- 30.0%, with United Republic of Tanzania ahead.
- How many years of comparable data are there for Americas and United Republic of Tanzania?
- 7 years are reported by both, from 2018 to 2024.
- How do Americas and United Republic of Tanzania rank globally for proportion of the target population who received the final dose of?
- Americas ranks 6th and United Republic of Tanzania ranks 5th of 35 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.